No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs545684581 |
chr4:19858501-19858502 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs564144351 |
chr4:19858514-19858515 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs531186581 |
chr4:19858525-19858526 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs545438504 |
chr4:19858563-19858564 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs549871051 |
chr4:19858655-19858656 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs143444888 |
chr4:19858667-19858668 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs188746371 |
chr4:19858686-19858687 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs529492199 |
chr4:19858732-19858733 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs561021760 |
chr4:19858748-19858749 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs566266598 |
chr4:19858755-19858756 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs540168431 |
chr4:19858819-19858820 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs73236299 |
chr4:19858826-19858827 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
13 |
rs11731860 |
chr4:19858865-19858866 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs570051609 |
chr4:19858871-19858872 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs537013517 |
chr4:19858875-19858876 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs555841979 |
chr4:19858876-19858877 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs73097665 |
chr4:19858897-19858898 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs11731893 |
chr4:19858961-19858962 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs534792114 |
chr4:19859032-19859033 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs147570040 |
chr4:19859045-19859046 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs368729296 |
chr4:19859066-19859067 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs34098775 |
chr4:19859116-19859117 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs142048425 |
chr4:19859129-19859130 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs543448359 |
chr4:19859163-19859164 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs369566843 |
chr4:19859191-19859192 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs563525100 |
chr4:19859200-19859201 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs371976542 |
chr4:19859251-19859252 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs145888565 |
chr4:19859325-19859326 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs575996823 |
chr4:19859331-19859332 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs543004193 |
chr4:19859341-19859342 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs561720266 |
chr4:19859392-19859393 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs34443482 |
chr4:19859393-19859394 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs532888624 |
chr4:19859406-19859407 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs138802460 |
chr4:19859455-19859456 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs547498077 |
chr4:19859466-19859467 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs192840403 |
chr4:19859501-19859502 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs539715929 |
chr4:19859511-19859512 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs142353443 |
chr4:19859548-19859549 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs537454320 |
chr4:19859566-19859567 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs533534504 |
chr4:19859585-19859586 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs73236300 |
chr4:19859596-19859597 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
42 |
rs570216140 |
chr4:19859639-19859640 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs537459530 |
chr4:19859643-19859644 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs549157405 |
chr4:19859650-19859651 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs567644591 |
chr4:19859742-19859743 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs534826676 |
chr4:19859751-19859752 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs73236302 |
chr4:19859776-19859777 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
48 |
rs375378662 |
chr4:19859804-19859805 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs539214112 |
chr4:19859847-19859848 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs528643155 |
chr4:19859944-19859945 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|